BMT CTN Protocol 0303

A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+ Enriched, T cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients with AML in First or Second Morphologic Complete Remission

Below are protocol-related documents, which may be periodically updated.

This study met its target enrollment and closed accrual on January 11, 2009.